Senesco Technologies Inc. (OTCMKTS:SVON) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Monday.

Shares of Senesco Technologies (OTCMKTS SVON) opened at 0.20 on Monday. The company’s 50 day moving average price is $0.27 and its 200 day moving average price is $0.25. The stock’s market capitalization is $5.38 million. Senesco Technologies has a 12 month low of $0.08 and a 12 month high of $0.38.

WARNING: “ValuEngine Downgrades Senesco Technologies Inc. (SVON) to Sell” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at

Senesco Technologies Company Profile

Sevion Therapeutics, Inc is a development-stage biotech company. The Company is engaged in building and developing a portfolio of therapeutics, from both internal discovery and acquisition, for the treatment of cancer and immunological diseases. The Company is engaged in the development and licensing of technology to discover and engineer monoclonal antibodies.

Receive News & Ratings for Senesco Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.